Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Amylyx Pharmaceuticals Inc’s stock clocked out at $3.00, down -8.54% from its previous closing price of $3.28. In other words, the price has decreased by -$8.54 from its previous closing price. On the day, 1.3 million shares were traded.
Ratios:
To gain a deeper understanding of AMLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.55. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 24 ’25 when Mazzariello Gina sold 4,169 shares for $3.15 per share. The transaction valued at 13,145 led to the insider holds 134,921 shares of the business.
Mazzariello Gina sold 3,678 shares of AMLX for $12,839 on Feb 03 ’25. The Chief Legal Officer now owns 139,090 shares after completing the transaction at $3.49 per share. On Feb 03 ’25, another insider, Cohen Joshua B, who serves as the Co-Chief Executive Officer of the company, sold 11,851 shares for $3.47 each. As a result, the insider received 41,108 and left with 3,201,247 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.31 while its Price-to-Book (P/B) ratio in mrq is 1.05.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $19.95, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -16.78%, while the 200-Day Moving Average is calculated to be -6.51%.
Shares Statistics:
A total of 68.55M shares are outstanding, with a floating share count of 62.25M. Insiders hold about 27.36% of the company’s shares, while institutions hold 58.38% stake in the company.
